NCT02932774View on ClinicalTrials.gov

Randomized, Double Blind, Parallel Group, Placebo Controlled, Multi-Center Study of the Efficacy and Safety of Cetirizine HCl Syrup vs. Loratadine Syrup vs. Placebo in Treatment of Children With Seasonal Allergic Rhinitis (SAR)

PHASE4CompletedINTERVENTIONAL
Enrollment

683

Participants

Timeline

Start Date

March 31, 2001

Primary Completion Date

July 31, 2001

Study Completion Date

July 31, 2001

Conditions
Allergic RhinitisHay FeverSARRhinitis, Allergic, Seasonal
Interventions
DRUG

Cetirizine

Cetirizine HCl 10 mg (1 mg/ml) syrup once daily before 10:00 AM for 2 weeks

DRUG

Loratadine

Loratadine HCl 10 mg (1 mg/ml) syrup once daily before 10:00 AM for 2 weeks

OTHER

Placebo

Placebo syrup once daily before 10:00 AM for 2 weeks

Sponsors

Collaborators (1)

Pfizer
All Listed Sponsors
collaborator

Pfizer

INDUSTRY

lead

Johnson & Johnson Consumer and Personal Products Worldwide

INDUSTRY